XML 99 R21.htm IDEA: XBRL DOCUMENT v3.24.3

Note 7 - Capital Stock and Reserves (Tables)

6 Months Ended

Sep. 30, 2024

Statement Line Items [Line Items]

Disclosure of number and weighted average exercise prices of share options [text block]

Expiry Date		Exercise Price				Balance March 31, 2024				Granted				Exercised				Forfeited / Expired				Balance September 30, 2024				Exercisable
March 8, 2025		$	15.50				4,000				-				-				-				4,000				4,000
September 2, 2025		$	12.75				20,000				-				-				-				20,000				20,000
September 6, 2025		$	13.75				8,000				-				-				-				8,000				8,000
November 20, 2025		$	4.00				6,000				-				-				-				6,000				6,000
December 2, 2025		$	9.00				62,000				-				-				(20,000	)			42,000				42,000
December 13, 2025		$	9.50				21,000				-				-				-				21,000				21,000
March 26, 2026		$	3.30				20,000				-				-				-				20,000				20,000
August 25, 2026		$	5.65				17,500				-				-				-				17,500				17,500
September 6, 2026		$	6.60				40,000				-				-				(7,500	)			32,500				32,500
November 1, 2026		$	7.50				10,000				-				-				-				10,000				10,000
December 4, 2026		$	5.47				20,000				-				-				-				20,000				20,000
September 6, 2028		$	6.60				85,000				-				-				(25,000	)			60,000				60,000
February 15, 2029		$	3.98				20,000				-				-				-				20,000				20,000
July 23, 2029		$	3.91				-				36,000				-				-				36,000				36,000
Total							333,500				36,000				-				(52,500	)			317,000				317,000
Weighted average exercise price						$	7.38			$	3.81			$	-			$	7.51			$	6.96			$	6.96
Weighted average remaining life (years)							2.61																2.51

Expiry Date		Exercise Price				Balance March 31, 2023				Granted				Exercised				Forfeited / Expired				Balance March 31, 2024				Exercisable
March 1, 2024		$	16.50				15,000				-				-				(15,000	)			-				-
November 14, 2024		$	3.65				-				36,000				(36,000	)			-				-				-
March 8, 2025		$	15.50				4,000				-				-				-				4,000				4,000
September 2, 2025		$	12.75				20,000				-				-				-				20,000				20,000
September 6, 2025		$	13.75				8,000				-				-				-				8,000				8,000
November 20, 2025		$	4.00				6,000				-				-				-				6,000				6,000
December 2, 2025		$	9.00				62,000				-				-				-				62,000				62,000
December 13, 2025		$	9.50				31,000				-				-				(10,000	)			21,000				21,000
January 15, 2026		$	7.25				35,300				-				-				(35,300	)			-				-
March 26, 2026		$	3.30				-				20,000				-				-				20,000				20,000
August 25, 2026		$	5.65				-				17,500				-				-				17,500				17,500
September 6, 2026		$	6.60				-				40,000				-				-				40,000				40,000
November 1, 2026		$	7.50				10,000				-				-				-				10,000				10,000
December 4, 2026		$	5.47				-				20,000				-				-				20,000				20,000
February 16, 2027		$	17.50				20,000				-				-				(20,000	)			-				-
September 6, 2028		$	6.60				-				85,000				-				-				85,000				85,000
February 15, 2029		$	3.98				-				20,000				-				-				20,000				20,000
		$	-				-				-				-				-				-				-
Total							211,300				238,500				(36,000	)			(80,300	)			333,500				333,500
Weighted average exercise price						$	10.81			$	5.87			$	4.70			$	9.95			$	7.38			$	7.38
Weighted average remaining life (years)							2.57																2.61

Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]

		September 30, 2024				March 31, 2024
Fair value per option		$	3.12			$	5.42
Exercise price		$	3.91			$	5.49
Expected life (years)			5.00				3.50
Interest rate			3.33	%			4.17	%
Annualized volatility (based on historical volatility)			109	%			108	%
Dividend yield			0.00	%			0.00	%

Disclosure of detailed information about warrant transactions [text block]

Expiry Date		Exercise Price				Balance March 31, 2024				Granted				Exercised				Forfeited / Expired				Balance September 30, 2024
August 24, 2028		$	USD 6.25				800,000				-				-				-				800,000
March 13, 2026		$	4.00				341,592				-				-				-				341,592
April 29, 2026		$	4.00				-				247,471				-				-				247,471
Total							1,141,592				247,471				-				-				1,389,063
Weighted average exercise price						$	5.58			$	4.00			$	-			$	-			$	5.30
Weighted average remaining life (years)							3.67																3.46

Expiry Date		Exercise Price				Balance March 31, 2023				Granted				Exercised				Forfeited / Expired				Balance March 31, 2024
December 2, 2023		$	6.50				24,000				-				-				(24,000	)			-
August 24, 2028		$	USD 6.25				-				800,000				-				-				800,000
March 13, 2026		$	4.00				-				341,592				-				-				341,592
Total							24,000				1,141,592				-				(24,000	)			1,141,592
Weighted average exercise price						$	6.50			$	5.58			$	-			$	6.50			$	5.58
Weighted average remaining life (years)							0.67																3.67

Expiry Date		Exercise Price				Balance March 31, 2024				Granted				Exercised				Cancelled / Expired				Balance September 30, 2024
August 19, 2024		$	10.00				5,765				-				-				(5,765	)			-
August 21, 2028		$	USD 6.25				40,000				-				-				-				40,000
March 13, 2026		$	3.40				3,274				-				-				-				3,274
April 29, 2026		$	3.40				-				51				-				-				51
Total							49,039				51				-				-				43,325
Weighted average exercise price						$	6.50			$	3.40			$	-			$	-			$	6.03
Weighted average remaining life (years)							2.94																3.88

Expiry Date		Exercise Price				Balance March 31, 2023				Granted				Exercised				Cancelled / Expired				Balance March 31, 2024
August 19, 2024		$	10.00				5,765				-				-				-				5,765
August 21, 2028		$	USD 6.25				-				40,000				-				-				40,000
March 13, 2026		$	3.40				-				3,274				-				-				3,274
Total							5,765				43,274				-				-				49,039
										$	USD 6.25
Weighted average exercise price						$	10.00			$	CAD 3.40			$	-			$	-			$	6.50
Weighted average remaining life (years)																							2.94

Disclosure of derivative financial instruments [text block]

		As at September 30, 2024				As at March 31, 2024				As at August 24, 2023
Number of warrants outstanding			800,000				800,000				800,000
Warrant price at valuation date		$	0.40 USD			$	0.61 USD			$	0.76 USD
Exchange rate			1.3514				1.35397				1.35460
Fair value of warrants outstanding (derivative liability)		$	428,663			$	656,946			$	823,597

Unit warrants expiring on both March 13, 2026 and April 29, 2026 [member]

Statement Line Items [Line Items]

Disclosure of indirect measurement of fair value of warrants granted during period [text block]

		September 30, 2024				March 31, 2024
Fair value per warrant		$	1.94			$	3.77
Exercise price		$	4.00			$	4.00
Expected life (years)			2.00				2.00
Interest rate			4.30	%			3.50	%
Annualized volatility (based on historical volatility)			100	%			111	%
Dividend yield			0.00	%			0.00	%

		September 30, 2024				March 31, 2024
Fair value per agent warrants		$	1.96			$	7.95
Exercise price		$	4.00			$	8.09
Expected life (years)			2.00				4.78
Interest rate			4.30	%			4.09	%
Annualized volatility (based on historical volatility)			101	%			113	%
Dividend yield			0.00	%			0.00	%

X

- Definition

The disclosure of detailed information about warrant transactions.

+ References

No definition available.

+ Details

Name:	fmst_DisclosureOfDetailedInformationAboutWarrantTransactionsTextBlock
Namespace Prefix:	fmst_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of information about indirect, by reference to the fair value of the warrant granted, measurement of the fair value of goods or services received as consideration for the entity's share options.

+ References

No definition available.

+ Details

Name:	fmst_DisclosureOfIndirectMeasurementOfFairValueOfWarrantsGrantedDuringPeriodTextBlock
Namespace Prefix:	fmst_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	fmst_Statement1LineItems
Namespace Prefix:	fmst_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of derivative financial instruments. [Refer: Derivatives [member]]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2024-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2024-01-01
-Paragraph 47
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_a&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2024-01-01
-Paragraph 45
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	ifrs-full_ClassesOfEntitysOwnEquityInstrumentsAxis=fmst_UnitWarrantsExpiringOnBothMarch132026AndApril292026Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: